ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis (RA) and risk assessment"

  • Abstract Number: 1596 • 2015 ACR/ARHP Annual Meeting

    Diagnosis of Carotid Plaque By 4 Cardiovascular Risk Scores in Rheumatoid Arthritis

    Raymundo Vera-Pineda1, Alberto Cardenas-de La Garza2, Dionicio A. Galarza-Delgado2, Jose Ramon Azpiri-Lopez3, Iris J. Colunga-Pedraza2, Judith Garcia-Colunga4, Guillermo Elizondo4, Mario Alberto Garza-Elizondo2, Jesus Zacarias Villarreal-Pérez5 and Griselda Serna-Peña6, 1Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 2Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 3Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 4Radiology, Hospital Universitario, UANL., Monterrey, Mexico, 5Endocrinology, Hospital Universitario, UANL., Monterrey, Mexico, 6Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico

    Background/Purpose: The leading cause of death in RA is atherosclerotic cardiovascular disease (ASCVD). Traditional risk factors do not explain the increased cardiovascular risk (CVR), which…
  • Abstract Number: 2305 • 2014 ACR/ARHP Annual Meeting

    Improving Screening for Hyperlipidemia in Patients with Rheumatoid Arthritis at an Academic Rheumatology Practice

    Ashwini Komarla1 and Alexis Ogdie2, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose Cardiovascular disease is the leading cause of mortality in the rheumatoid arthritis (RA) population. However, cardiovascular risk factors such as hyperlipidemia are undertreated in…
  • Abstract Number: 1442 • 2014 ACR/ARHP Annual Meeting

    The 2013 ACC/AHA Cardiovascular Risk Prediction Model and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis

    Vivian K. Kawai1, Cecilia P. Chung2, Joseph F. Solus1, Annette Oeser1, Paolo Raggi3 and C. Michael Stein1, 1Vanderbilt University, Nashville, TN, 2Medicine, Vanderbilt University, Nashville, TN, 3University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Patients with rheumatoid arthritis (RA) have increased risk of atherosclerotic cardiovascular (CV) disease  that is underestimated by the Framingham risk score (FRS). We hypothesized…
  • Abstract Number: 1423 • 2014 ACR/ARHP Annual Meeting

    Cardiovascular Risk Estimation in Rheumatoid Arthritis: What Is Missing in Traditional Risk Estimators?

    Gulsen Ozen1, Murat Sunbul2, Pamir Atagunduz1, Haner Direskeneli1, Kursat Tigen2 and Nevsun Inanc1, 1Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, 2Department of Cardiology, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose: Cardiovascular (CV) disease is one of the major causes of mortality in rheumatoid arthritis (RA). Although the CV risk in RA is well-recognized, detection…
  • Abstract Number: 1390 • 2014 ACR/ARHP Annual Meeting

    Heterogeneity in Cardiovascular Risk Factors, Event Rates and RA Disease Characteristics Among Patients with Rheumatoid Arthritis Across 10 Countries – Implications for CV Risk Assessment

    Atacc-RA Collaborative Group, Division of Rheumatology, Mayo Clinic, Rochester, MN; Diakonhjemmet hospital, Oslo, Norway; Dudley Group NHS Foundation Trust, West Midlands, United Kingdom; Radboud University Medical Center, Nijmegen, Netherlands; University of Umeå, Umeå, Sweden; University of Athens, Athens, Greece; Harbor UCLA Medical Center, Torrance, CA; Harvard Medical School Brigham and Women's Hospital, Boston, MA; Hospital Universitario Marques de Valdecilla, Santander, Spain; School of Physiology, Faculty of Health Sciences, Witwatersrand University, Johannesburg, South Africa; University of Manitoba, Winnipeg, MB, Canada; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubir, México City, Mexico; Hospital Medisch Spectrum Twente, Enschede, Netherlands

    Background/Purpose Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD). CVD risk scores for the general population do not accurately predict…
  • Abstract Number: 1361 • 2014 ACR/ARHP Annual Meeting

    Rheumatologists’ Attitudes on Cardiovascular Risk and Lipid Screening in Patients with Rheumatoid Arthritis at an Academic Medical Center

    Ashwini Komarla1 and Alexis Ogdie2, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Cardiovascular (CV) disease is a major cause of morbidity and mortality in the rheumatoid arthritis (RA) population. Thus, the recognition and management of cardiovascular…
  • Abstract Number: 1064 • 2014 ACR/ARHP Annual Meeting

    Unique Profile of Cardiovascular Risk Factors in Rheumatoid Arthritis High-Risk Populations with Insufficient Risk Control

    Ulf Müller-Ladner1, Stefan Kleinert2, Klaus Krüger3, Bianca Wittig4 and Rolf Hecker4, 1Rheumatologie und klinische Immunologie, Kerckhoff-Klinik GmbH, Abt. Rheumatologie und klinische Immunologie, Bad Nauheim, Germany, 2Rheumatologie, Praxisgemeinschaft Rheumatologie-Nephrologie, Rheumatologische Schwerpunktpraxis, Erlangen, Germany, 3Praxiszentrum St. Bonifatius, München, Germany, 4Abbvie Deutschland GmbH & Co. KG, Wiesbaden, Germany

    Background/Purpose More than 50% of premature deaths in patients with rheumatoid arthritis (RA) are due to cardiovascular disease (CVD). Both the cumulative burden of inflammation…
  • Abstract Number: 842 • 2014 ACR/ARHP Annual Meeting

    Is Rheumatoid Arthritis a Coronary Heart Disease Risk Equivalent, Similar to Diabetes?

    Jie Zhang1, Shuo Yang2, Lang Chen3, Fenglong Xie4, Huifeng Yun5, Paul M. Muntner6, Emily Levitan6, Monica Safford7, Kenneth G. Saag8, Jasvinder A. Singh7 and Jeffrey R. Curtis7, 1Ryals Soph Bldg., Rm. 517b, Univ. of Alabama at Birmingham, Birmingham, AL, 2Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 5Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, 6Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 7University of Alabama at Birmingham, Birmingham, AL, 8Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Recently cholesterol treatment guidelines recommend that diabetes (DM) should be considered a CVD risk equivalent to a history of coronary heart disease (CHD). Despite…
  • Abstract Number: 2656 • 2013 ACR/ARHP Annual Meeting

    Performance Of Prediction Models For Rheumatoid Arthritis Serologic Phenotypes Among Women Using Family History, Genetics and Environmental Factors

    Jeffrey A. Sparks1, Chia-Yen Chen2, Xia Jiang3, Linda T. Hiraki4, Lars Klareskog5, Lars Alfredsson3, Karen H. Costenbader6 and Elizabeth W. Karlson1, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Epidemiology, Harvard School of Public Health, Boston, MA, 3Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard School of Public Health, Boston, MA, 5Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 6Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Family history (FH) of autoimmunity, genetics, and environmental factors have been associated with RA. The area under the receiver operating characteristic curve (AUC) can…
  • Abstract Number: 1378 • 2013 ACR/ARHP Annual Meeting

    Associations Of Periodontitis (PD) With Established Seropositive Rheumatoid Arthritis are Independent of Smoking and Other Risk Factors

    Ted R. Mikuls1, Jeffrey Payne2, Fang Yu3, Geoffrey M. Thiele4, Richard J. Reynolds5, Grant W. Cannon6, Jeffrey Markt7, David McGowan8, Gail S. Kerr9, Robert Redman10, Andreas M. Reimold11, Garth Griffiths12, Mark Beatty2, Shawneen Gonzalez2, Debra Bergman13, Bartlett C. Hamilton III14, Alan R. Erickson1 and James R. O'Dell15, 1Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 2College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 3University of Nebraska Medical Center, Omaha, NE, 4Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE, 5Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 7Otol-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, 8Dentistry, George E. Wahlen VA Medical Center, Salt Lake City, UT, 9Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 10Dentistry, Washington DC VA, Georgetown and Howard University, Washington, DC, 11Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, 12Dentistry, Dallas VA and University of Texas Southwestern, Dallas, TX, 13Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 14University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 15Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Periodontitis (PD) has been proposed as a risk factor in RA.  Reports have suggested that this association may be due to confounding from smoking…
  • Abstract Number: 1396 • 2013 ACR/ARHP Annual Meeting

    Survivin–positivity Increases Risk For RA and Has a Strong Additive Effect On The Shared Epitope Alleles and Antibodies To Citrullinated Peptides In Patients Of The Malaysian Epidemiological Investigation Of Rheumatoid Arthritis (MyEIRA) Study Group

    Chun Lai Too1, Shahnaz Murad2, Malin Erlandsson3, Heselynn Hussein4, Wahinuddin Sulaiman5, Jasbir Singh Dhaliwal1 and Maria Bokarewa3, 1Institute for Medical Research, Allergy and Immunology Research Center, Jalan Pahang, Kuala Lumpur, Malaysia, 2Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia, 3Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden, 4Department of Medicine, Putrajaya Hospital, Putrajaya, Malaysia, 5Department of Medicine, Tengku Bainun Hospital, Ipoh, Perak, Malaysia

    Background/Purpose: The human leukocyte antigen (HLA)-DRB1 with alleles that contain common amino acid motif QKRAA termed shared epitope (SE) confer the major locus of genetic…
  • Abstract Number: 1348 • 2013 ACR/ARHP Annual Meeting

    Initial Combination Therapy In Early Rheumatoid Arthritis: Which Patients Benefit?

    I.M. Markusse1, K.H. Han2, A.J. Peeters3, H.K Ronday4, P.J.S.M. Kerstens5, T.W.J. Huizinga1, W.F. Lems6 and C.F. Allaart1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 3Rheumatology, Reinier de Graaf Gasthuis, Delft, Netherlands, 4Rheumatology, Haga Hospital, The Hague, Netherlands, 5Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 6Rheumatology, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Initial combination therapy has proven to be effective in early rheumatoid arthritis (RA) patients. To determine which patients benefit from initial combination therapy.  Methods:…
  • Abstract Number: 111 • 2013 ACR/ARHP Annual Meeting

    Identifying Groups At Increased Risk Of Developing Rheumatoid Arthritis Using Family History and Genetic Risk Scores

    Jeffrey A. Sparks1, Chia-Yen Chen2, Xia Jiang3, Johan Askling4, Linda T. Hiraki5, Lars Klareskog6, Lars Alfredsson3, Karen H. Costenbader7 and Elizabeth W. Karlson1, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Epidemiology, Harvard School of Public Health, Boston, MA, 3Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, 5Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard School of Public Health, Boston, MA, 6Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 7Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: The identification of high risk groups is crucial for RA prevention strategies. Individuals with family history (FH) of autoimmunity are at increased risk for…
  • Abstract Number: 2826 • 2013 ACR/ARHP Annual Meeting

    Performance Of Five Current Risk Algorithms In Predicting Cardiovascular Events In Rheumatoid Arthritis Patients

    Elke.E.A. Arts1, Calin Popa1, Alfons A. den Broeder2, Anne G. Semb3, Tracey Toms4, George Kitas4, Piet L.C.M. van Riel1 and Jaap Fransen5, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, United Kingdom, 5Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Cardiovascular risk in rheumatoid arthritis (RA) is increased. The cardiovascular (CV) risk algorithms used in the general population may underestimate the risk of cardiovascular…
  • Abstract Number: 2828 • 2013 ACR/ARHP Annual Meeting

    The Performance Of The Original and An Updated Cardiovascular Risk Algorithm (SCORE)  In Patients With Rheumatoid Arthritis

    Elke.E.A. Arts1, Calin Popa1, Alfons A. den Broeder2, Anne Grete Semb3, Tracey Toms4, George Kitas4, Piet L.C.M. van Riel1 and Jaap Fransen1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, United Kingdom

    Background/Purpose: Cardiovascular (CV) risk in rheumatoid arthritis (RA) is increased. The CV risk algorithms for the  general population may underestimate the risk of cardiovascular disease…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology